Protein C global assay in the evaluation of women with idiopathic pregnancy loss

Thrombosis and Haemostasis

Volumn 88, Issue 1, 2002, Pages 32-36

  Sarig, Galit ^a   Lanir, Naomi ^a   Hoffman, Ron ^a   Brenner, Benjamin ^a  

^a RAMBAM MEDICAL CENTER   (Israel)

Author keywords

Pregnancy loss; Protein C pathway; Thrombophilia

Indexed keywords

ACTIVATED PROTEIN C; BLOOD CLOTTING FACTOR 5 LEIDEN; PROTEIN C; PROTEIN S; PROTHROMBIN;

ACTIVATED PROTEIN C RESISTANCE; ADULT; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; HUMAN; IDIOPATHIC DISEASE; MAJOR CLINICAL STUDY; MEDICAL DOCUMENTATION; NORMAL VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN ANALYSIS; PROTEIN DETERMINATION; REFERENCE VALUE; RISK FACTOR; SCREENING TEST; SENSITIVITY AND SPECIFICITY; SPONTANEOUS ABORTION; THROMBOPHILIA; TIME; BLOOD; BLOOD CLOTTING TEST; CASE CONTROL STUDY; FETUS DEATH; MIDDLE AGED; PREGNANCY; PREGNANCY COMPLICATION; STANDARD;

ABORTION, SPONTANEOUS; ADULT; BLOOD COAGULATION TESTS; CASE-CONTROL STUDIES; FEMALE; FETAL DEATH; HUMANS; MIDDLE AGED; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; PROSPECTIVE STUDIES; PROTEIN C; RISK FACTORS; SENSITIVITY AND SPECIFICITY; THROMBOPHILIA;

EID: 0036308036     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1613149     Document Type: Article

References (27)

1. Intrauterine growth restriction in infants of less than thirty-two weeks' gestation: Associated placental pathologic features
2. An informative protocol for the investigation of recurrent miscarriage: Preliminary experience of 500 consecutive cases
3. Antiphospholipid antibodies and recurrent pregnancy loss
4. Thrombophilia-associated pregnancy wastage
5. The risk of abortion and stillbirth in antithrombin-, protein C-, and protein S-deficient women
6. Increased fetal loss in women with heritable thrombophilia
7. Factor V Leiden mutation as a risk factor for recurrent pregnancy loss
8. Factor V Leiden is associated with repeated and recurrent unexplained fetal loss
9. Second-trimester pregnancy loss is associated with activated protein C resistance
10. Activated protein C resistance can be associated with recurrent fetal loss
11. Thrombophilic polymorphisms are common in women with fetal loss without apparent cause
12. Increased risk for fetal loss in carriers of the factor V Leiden mutation
13. A possible role for activated protein C resistance in patients with first and second trimester pregnancy failure
14. Anticoagulant response to Agkistrodon contortrix venom (ACV test): A new global test to screen for defects in the anticoagulant protein C pathway
15. ProC Global: The first functional screening assay for the complete protein C pathway
16. Laboratory screening of thrombophilia. Evaluation of the diagnostic efficacy of a global test to detect congenital deficiencies of the protein C anticoagulant pathway
17. Screening for abnormalities of the protein C anticoagulant pathway using the ProC Global assay. Results of European multicenter evaluation
18. Diagnostic methodologies for circulating anticoagulants
19. Increased frequency of genetic thrombophilia in women with complications of pregnancy
20. Thrombophilia is common in women with idiopathic pregnancy loss and is associated with late pregnancy wastage
21. Normal prevalence of the G20210A prothrombin gene mutation in women with recurrent miscarriage
22. Hyperhomocysteinemia and recurrent early pregnancy loss: A meta-analysis
23. Mutations in coagulation factors in women with unexplained late fetal loss
24. The reduced sensitivity of the ProC® Global test in protein S deficient subjects reflects a reduction in the associated thrombotic risk
25. Endothelial cell protein C receptor plays an important role in protein C activation in vivo
26. Mechanisms by which soluble endothelial cell protein C receptor modulates protein C and activated protein C function
27. Gestational outcome of thrombophilic women with recurrent pregnancy loss treated by enoxaparin